Oncotarget a primarily oncology-focused, peer-reviewed, open access journal aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.
The term was introduced in the inaugural Editorial , Introducing Oncotarget. As of January 1, , Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Post-Publication Promotion Services. Impact Journals is a member of the Society for Scholarly Publishing. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control.
This malicious action will be reported to the FBI. Keywords : targeted therapies; tyrosine-kinase inhibitors; non-small cell lung cancer; EGFR; elderly; Gerotarget. Patients and methods. A performance status of 0—1 or 2—3 at diagnosis was reported for Overall, EGFR mutations were identified mainly on exon 19 A geriatric assessment was performed in TKI treatment was administered to Overall response rate and disease control rate were Median progression-free survival was Main toxicities were cutaneous for Geriatric assessment appeared to be underused in this population.
Lung cancer is the most common cancer worldwide and is the leading cause of cancer death in Western countries [ 1 ]. However, NSCLC is often diagnosed when metastases are present or when the disease is at an advanced stage. With the growing of aging population, elderly patients with lung cancer will be more frequent [ 3 ].
